EUVIMEDEUVIMED entdecken
Open Access

Risk of fall or fracture with concomitant use of prescription opioids and other medications in osteoarthritis patients

Nazleen F Khan iD, Katsiaryna Bykov iD, Jeffrey N Katz, Robert J Glynn iD, Seanna M Vine, Seoyoung C Kim iD

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.5773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Nazleen F Khan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass…. Hauptthemen laut MEDLINE: Osteoarthritis, Fractures, Bone, Prescription Drugs. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIA NIH HHS, AHRQ HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteoarthritis (OA) patients taking prescription opioids for pain are at increased risk of fall or fracture, and the concomitant use of interacting drugs may further increase the risk of these events.

Aims

To identify prescription opioid‐related medication combinations associated with fall or fracture. Materials & Methods We conducted a case‐crossover‐based screening of two administrative claims databases spanning 2003 through 2021. OA patients were aged 40 years or older with at least 365 days of continuous enrollment and 90 days of continuous prescription opioid use before their first eligible fall or fracture event. The primary analysis quantified the odds ratio (OR) between fall and non‐opioid medications dispensed in the 90 days before the fall date after adjustment for prescription opioid dosage and confounding using a case‐time‐control design. A secondary analogous analysis evaluated medications associated with fracture. The false discovery rate (FDR) was used to account for multiple testing.

Results

We identified 41 693 OA patients who experienced a fall and 24 891 OA patients who experienced a fracture after at least 90 days of continuous opioid therapy. Top non‐opioid medications by ascending p‐value with OR > 1 for fall were meloxicam (OR 1.22, FDR = 0.08), metoprolol (OR 1.06, FDR >0.99), and celecoxib (OR 1.13, FDR > 0.99). Top non‐opioid medications for fracture were losartan (OR 1.20, FDR = 0.80), alprazolam (OR 1.14, FDR > 0.99), and duloxetine (OR 1.12, FDR = 0.97).

Conclusion

Clinicians may seek to monitor patients who are co‐prescribed drugs that act on the central nervous system, especially in individuals with OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisFractures, BonePrescription DrugsHumansAnalgesics, OpioidPrescriptions

Stichwörter der Autor:innen

drug-drug interactionsepidemiologyfallfractureopioidspharmacoepidemiology

Substanzen

Analgesics, OpioidPrescription Drugs

Autor:innen und Institutionen

  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Orthopedics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

ORCID-Profile: Nazleen F Khan, Katsiaryna Bykov, Robert J Glynn, Seoyoung C Kim

Förderung

  • NIAMS NIH HHS
  • NIA NIH HHS
  • AHRQ HHS
  • National Institute on Aging
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Khan, N. F., Bykov, K., Katz, J. N., Glynn, R. J., Vine, S. M., & Kim, S. C. (2024). Risk of fall or fracture with concomitant use of prescription opioids and other medications in osteoarthritis patients. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5773

Vancouver

Khan NF, Bykov K, Katz JN, Glynn RJ, Vine SM, Kim SC. Risk of fall or fracture with concomitant use of prescription opioids and other medications in osteoarthritis patients. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5773

BibTeX
@article{Khan2024,
  author = {Khan, Nazleen F and Bykov, Katsiaryna and Katz, Jeffrey N and Glynn, Robert J and Vine, Seanna M and Kim, Seoyoung C},
  title = {Risk of fall or fracture with concomitant use of prescription opioids and other medications in osteoarthritis patients},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.5773}
}
Kostenlos starten →